Trevi Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.About TRVI
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis (IPF), non-IPF interstitial lung disease, and refractory chronic cough.
TRVI Key Statistics
Stock Snapshot
Trevi Therapeutics(TRVI) stock is priced at $17.18, giving the company a market capitalization of 2.44B. It carries a P/E multiple of -55.15.
As of 2026-07-13, Trevi Therapeutics(TRVI) stock has fluctuated between $17.18 and $18.00. The current price stands at $17.18, placing the stock 0.0% above today's low and -4.6% off the high.
The Trevi Therapeutics(TRVI)'s current trading volume is 48.03K, compared to an average daily volume of 3.12M.
In the last year, Trevi Therapeutics(TRVI) shares hit a 52-week high of $20.15 and a 52-week low of $6.25.
In the last year, Trevi Therapeutics(TRVI) shares hit a 52-week high of $20.15 and a 52-week low of $6.25.
TRVI News
Trevi Therapeutics (TRVI) announced an update on their ongoing clinical study. TipRanks has entered a new arena in the investing world, powering the index of a...
Trevi Therapeutics (TRVI) was recently removed from several Russell indexes, including the Russell 3000E and Russell Microcap families. This index reshuffle can...
...
Analyst ratings
100%
of 11 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.